بررسی رابطه بین ریسک تجاری و ریسک مالی با عملکرد شرکت‌های دارویی پذیرفته شده در بورس اوراق بهادار تهران

نوع مقاله : مقاله پژوهشی

نویسندگان

1 استادیار گروه اقتصاد دانشگاه پیام نور، تهران.

2 کارشناسی ارشد مدیریت مالی، دانشگاه آزاد اسلامی، واحد علوم و تحقیقات تهران، دانشکده مدیریت و اقتصاد

3 کارشناسی ارشد حسابداری از دانشگاه علوم اقتصادی

چکیده

مقدمه: معیارها و روش‌های مختلفی برای ارزیابی عملکرد شرکت‌ها وجود دارد. یکی از این معیارها، نسبت کیوتوبین است. هدف پژوهش حاضر بررسی رابطه نسبت کیوتوبین با ریسک تجاری و ریسک مالی است. برای محاسبه ریسک تجاری از درجه اهرم عملیاتی و برای محاسبه ریسک مالی از درجه اهرم مالی استفاده شده است.
روش پژوهش: جامعه آماری پژوهش حاضر شامل کلیه شرکت‌های دارویی پذیرفته شده در بورس اوراق بهادار تهران است که در نهایت 20 شرکت واجد شرایط طی دوره 1386 الی 1390 انتخاب شد. هم‌چنین، برای آزمون فرضیه‌های پژوهش از روش رگرسیون ترکیبی استفاده شده است.
یافته‌ها: نتایج پژوهش نشان می‌دهد که بین نسبت کیوتوبین و اهرم عملیاتی رابطه معناداری وجود نداشته ولی نسبت کیوتوبین با اهرم مالی شرکت‌های دارویی پذیرفته شده در بورس اوراق بهادار تهران رابطه معکوس و معنادار دارد.
نتیجه‌گیری: براساس یافته‌های پژوهش حاضر، ریسک تجاری تأثیری بر عملکرد شرکت‌های دارویی نداشته درحالی‌که ریسک مالی تأثیر معکوسی بر عملکرد شرکت‌های دارویی دارد و با افزایش بدهی شرکت‌های دارویی، عملکرد آن‌ها کاهش پیدا می‌کند.

کلیدواژه‌ها

عنوان مقاله [English]

Investigating the Relationship between Business Risk and Financial Risk with Performance of Pharmaceutical Companies Listed on Tehran Stock Exchange

نویسندگان [English]

  • H. Mirzaei 1
  • M. R. Khataee 2
  • Y. Ghanbari 3
1 Assistant Professor of Department of Economics, Payam Noor University
2 Master of Financial Management, Faculty of Management and Economics-Science and Research Branch, Islamic Azad University, Tehran, Iran.
3 Master of Accounting, University of Economic Sciences
چکیده [English]

Introduction: There are different criteria and methods for evaluating the performance of companies one of which is Tobin's Q ratio. The purpose of the current study is to investigate the relationship between Tobin's Q ratio with business and financial risk. Operation leverage and financial leverage were used to calculate the business risk and financial risk, respectively.
Method: Statistical sample of the present study consists of all pharmaceutical companies listed on Tehran Stock Exchange. Out of them, ultimately 20 companies which were eligible during 2007-2012 were selected. Also, Panel Data Analysis method was used to test the research hypotheses.
Results: The results of this research indicated that there was no significant relationship between Tobin's Q ratio and operation leverage but there was significant and inverse relationship between Tobin's Q ratio with financial leverage of pharmaceutical companies listed on Tehran Stock exchange.
Conclusion: Given the findings of the study, it can be concluded that commercial risk has no effect on pharmaceutical companies, while financial risk has negative effect in that as the debt of companies increases, their performance is reduced.

کلیدواژه‌ها [English]

  • Tobin's Q Ratio
  • Business Risk
  • Operation Leverage
  • Financial Risk
  • Financial Leverage

مراجع

1        Kashanipour, M. and A. Rasaiian (2009). “The Relationship between Tobin's Q and Criteria for Assessing the Performance of Companies in Iran”. Journal of Financial Accounting, Vol. 1, No. 3, pp. 131-146. [In Persian]
2        Heydarpour, F. and H. Mostofi (2009). “Examining the Relationship between Tobin's Q ratio and EVA Refining of Companies Listed on Tehran Stock Exchange”. Journal of Financial Accounting, Vol. 1, No. 1, pp. 21-26. [In Persian]
3        Wolfe, J. (2003). “The Tobin's Q as a Company Performance Indicator”. Journal of Developments in Business Simulation and Experimental Learning, No. 30, pp. 155-160.
4        Rahnamaye Roodposhti, F. and F. Mousaviye Sabet (2008). “Investigating the Amount of Relationship between Continuing Activities and Stock Price”. Journal of Financial Studies, Vol. 1, No. 1, pp. 71-92. [In Persian]
5        Roodposhti Roodposhti, F.; Nikoumaram, H.; and S. Shahverdiyani (2010). Strategic Financial Management (Value Creation-Risk Based Management), 1st Edition, Tehran: Hakimbashi Publications. [In Persian]
6        Foster, G. (1986). Financial Statement Analysis. New Jersey: Prentice-Hall, Inc.
7        Baum, Ch. L.; Sarver, L.; and T. Strickland (2004). “EVA, MVA and CEO Compensation: Further Evidence”, American Business Review, Vol. 22, No. 2, pp. 82-89.
8        Bacidore, J. M.; Boquist, J. A.; Milbourn, T.; and A. V. Thakor (1997). “The Search for the Best Financial Performance Measure”, Financial Analysts Journal, Vol. 53, No. 3, pp. 11-20.
9        Chin, Ch. L.; Lee, P.; and H. Y. Chi (2006). “Patent Citation, R&D Spillover, and Tobin's Q: Evidence from Taiwan Semiconductor Industry”. Review of Quantitative Finance and Accounting, Vol. 26, No. 1, pp. 67-84.
10    Wu, J.; Zhang, L.; and X. F. Zhang (2010). “The Q-Theory Approach to Understanding the Accrual Anomaly”, Journal of Accounting Research, Vol. 48, No. 1, pp. 177-223.
11    Julio, B. and Y. Yook. (2012). “Political Uncertainty and Corporate Investment Cycles”. The Journal of Finance, Vol. 67, No. 1, pp. 45-83.
12    Abbasi, E. and B. Ebrahimzadeh Rahimloo (2011). “Investigating the Effect of Tobin's Q ratio and the Growth Rate of Earnings on Investments of Companies Listed on Tehran Stock Exchange”. Journal of Investment Knowledge, Vol. 1, No. 1, pp. 83-97. [In Persian]
13    Namazi, M. and R. Zeratgari (2009). “The Evaluation of Tobin's Q ratio Application and its Comparison with Other Measures of Performance Management in Companies Listed on Tehran Stock Exchange”, Journal of Advances in Accounting, Vol. 1, No. 1, pp. 232-262. [In Persian]
14    Arabsalehi, M.; Moayedfar, R.; and S. Karimi (2011). “The Impact of Environmental Risk, Corporate Strategy and Capital Structure on the Performance of Companies Listed on Tehran Stock Exchange”, Journal of Financial Accounting Research, Vol. 4, No. 3, pp. 47-70. [In Persian]
15    Faff, R.; Hillier, D.; and S. R. Mohamed (2010). “Exploring the Link between Information Quality and Systematic Risk: Corporate Insider Trading as an Illustrative Case”, Journal of Financial Research, In press. Available at: http://www.efmaefm.org/efma2005/papers/108-hillier_paper.pdf. (2004)
16    Chathoth, K. P. and M. D. Olsen. (2007). “The Effect of Environment Risk, Corporate Strategy, and Capital Structure on Firm Performance”, Journal of Hospitality Management, Vol. 26, pp. 502- 516.
17    Houmes, R. E.; MacArthur, J. B.; and H. Stranahan (2012). “The Operating Leverage Impact on Systematic Risk within a Context of Choice: An Analysis of the US Trucking Industry”, Managerial Finance, Vol. 38, No. 12, pp. 1184-1202.
18    Akinyomi, O. and A. Olagunju (2013). “Determinants of Capital Structure in Nigeria”, International Journal of Innovation and Applied Studies, Vol. 3, No. 4, pp. 999-1005.
19    Ahmadpour, A. and H. Amouzadeh Mehdiraji (2007). “Examining the Impact of Business Risk and Financial Risk on the Investment Portfolios of Insurance Companies in Asia listed on Tehran Stock Exchange”, Journal of Insurance Industry, Vol. 22, No. 1, pp. 114-116. [In Persian]
20    Coricelli, F.; Driffield, N.; Pal, S.; and I. Roland (2012). “When Does Leverage Hurt Productivity Growth? A Firm-Level Analysis”. Journal of International Money and Finance, Vol. 31, No. 6, pp. 1674-1694.
21    Jermias, J. (2008). “The Relative Influence of Competitive Intensity and Business Strategy on the Relationship between Financial Leverage and Performance”, The British Accounting
Review, Vol. 40, pp. 71-86.
22    Veliyath, R. (1996). “Business Risk and Performance: An Examination of Industry Effects”. Journal of Applied Business Research, Vol. 12, No. 3, pp. 37-47.
23    Dimitro, V. and P. C. Jain (2005). “The Value Relevance of Changes in Financial Leverage”. Journal of Accounting and Finance, Vol. 21, No. 1, pp. 230-250.
24    Dadashi, E.; Asghari, M.; Zarei, S.; and M. Jafari Baie (2013). “Examining the Effect of Capital Structure and Financing on the Technical Efficiency of the Pharmaceutical Companies listed on Tehran Stock Exchange”, Journal of Health Accounting, Vol. 2, No. 1, Issue. 3, pp. 1-19. [In Persian]
25    Abbasi, E.; Ahmadi, S.; and E. Heydari (2013). “The Ranking of the Pharmaceutical Industry Companies with an Integrative Approach to Multi-Criteria Decision Making and Genetic Algorithms”, Journal of Health Accounting, Vol. 2, No. 1, Issue. 3, pp. 57-77. [In Persian]
26    Salehi, M.; Valipour, H.; and F. Akhtarshenas (2013). “Examining the Effect of Audit Report on Financing (Borrowings from Banks) the Pharmaceutical Companies listed on Tehran Stock Exchange”, Journal of Health Accounting, Vol. 2, No. 1, Issue. 3, pp. 35-56. [In Persian]

فایل ها

هم رسانی

ارجاع به این مقاله

آمار